SCHEMBL6168964

SCHEMBL6168964

CCOC(=O)c1ccc([N+](=O)[O-])c(NC(=O)COCCc2ccc(-c3ccccc3)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.48
CYP1A2 P05177 1/20 0.48
KMT2A Q03164 2/20 0.48
LMNA P02545 2/20 0.47
MAPT P10636 6/20 0.46
MAPK1 P28482 1/20 0.46
POLB P06746 2/20 0.46
THRB P10828 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
ALDH1A1 P00352 8/20 0.45
TDP1 Q9NUW8 1/20 0.45
MEN1 O00255 1/20 0.45
PTGER4 P35408 1/20 0.45
NPC1 O15118 2/20 0.45
PKM P14618 1/20 0.45
CRHBP P24387 1/20 0.45
CRHR2 Q13324 1/20 0.45
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6197844 0.89 LMNA (0.51) RAB9ACYP1A2KMT2ALMNAMAPT
SCHEMBL6172642 0.87 RAB9A (0.56) RAB9ACYP1A2KMT2ALMNAMAPT
SCHEMBL6169173 0.83 MAPT (0.65) RAB9AKMT2ALMNAMAPTPOLB
SCHEMBL6196999 0.81 L3MBTL1 (0.52) RAB9AKMT2ALMNAMAPTMAPK1
SCHEMBL6169048 0.80 PKM (0.60) RAB9AKMT2ALMNAMAPTMAPK1
SCHEMBL6169035 0.80 RAB9A (0.59) RAB9AKMT2ALMNAMAPTPOLB
SCHEMBL6172633 0.80 KMT2A (0.49) RAB9ACYP1A2KMT2ALMNAMAPT
SCHEMBL6169157 0.79 KMT2A (0.60) RAB9AKMT2ALMNAMAPTMAPK1
SCHEMBL6171231 0.79 MAPT (0.50) RAB9AKMT2ALMNAMAPTPOLB
SCHEMBL6170456 0.79 RAB9A (0.46) RAB9ACYP1A2KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed